We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App




Sound Waves Separate Tumor and Blood Cells

By LabMedica International staff writers
Posted on 10 Sep 2014
A device has been developed that can test a cancer patient's blood for rare tumor cells and will be extremely useful for checking if a tumor is going to spread.

The relatively small device uses “tilted” sound waves, offering an effective way of sorting cells without having to treat them with chemicals or deform them mechanically. More...
These sound waves cross the cells' trajectory at an angle instead of going straight across, ensuring that each cell encounters several low-pressure nodes on its journey through the microchannel instead of just one.

Scientists at the Pennsylvania State University (University Park, PA, USA) working with colleagues from other institutes developed a unique configuration of tilted-angle standing surface acoustic waves (taSSAW),which are oriented at an optimally designed inclination to the flow direction in the microfluidic channel. To optimize the device design, they carried out systematic simulations of cell trajectories, matching closely with experimental results.

In their study, the team first tested their device using plastic beads and showed it could separate beads of 9.9 micrometers from beads of 7.3 micrometers in diameter with around 97% accuracy. The team also tested how well the device was able to separate a human breast cancer epithelial cell line Michigan Cancer Foundation-7 (MCF-7) that are 20 micrometers diameter from white blood cells that are about 12 micrometers in diameter. The cells also differ by compressibility and density. The results showed the cell sorter recovered around 71% of the cancer cells. One of the tests used to test cell viability and proliferation was the BrdU Cell Proliferation enzyme-linked immunosorbent assay (Roche Diagnostics, Indianapolis, IN, USA).

The team now plans to test the 18 mm device with blood samples from cancer patients in clinical settings. Circulating tumor cells are very rare as 1 mL of a typical cancer patient's blood may only contain a few tumor cells. The scientists have filed for a patent on their device. They see it helping clinicians determine whether a patient's tumor is about to spread to other sites of the body as tumors that are about to metastasize begin to send out cells that travel through the bloodstream.

The authors concluded that the simple design, low cost, and standard fabrication process of the device allows for easy integration with other laboratory-on-a-chip technologies and small radio frequency (RF) power supplies to further develop a fully integrated cell separation and analysis system. The study was published on August 25, 2014, in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS).

Related Links:

Pennsylvania State University 
Roche Diagnostics 



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Drug Test Kit
DrugCheck 3000
New
Specimen Radiography System
TrueView 200 Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.